A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review
Clinical trial NCT06362031 · WITHDRAWN
Trial details
- NCT number
- NCT06362031
- Sponsor
- AbbVie
- Status
- WITHDRAWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-01
- Primary completion
- 2024-04-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.